OBJECTIVE: Increased free fatty acids (FFAs) are leading candidates in the pathogenesis of insulin resistance and hypertension in obese subjects. We evaluated the effect of sustained elevations of FFA on blood pressure, endothelial function, insulin secretion, inflammatory markers, and renin-angiotensin system. RESEARCH DESIGN AND METHODS: Twenty-four obese, African-American, normotensive diabetic subjects received a sequential 48-h infusion of Intralipid (20%, 40 ml/h) plus heparin (250 units/h) or normal saline (40 ml/h) plus heparin (250 units/h). RESULTS:Blood pressure was significantly increased within 4 h of lipid infusion and reached a peak increment of 13 mm Hg in systolic and 5 mm Hg in diastolic blood pressure at 24 h (P < 0.01). Compared to baseline, lipid infusion reduced flow-mediated dilatation by 11% at 24 h and 18% at 48 h (P < 0.001). FFA and triglyceride levels increased from a baseline of 0.5 +/- 0.2 mmol/liter and 135 +/- 76 mg/dl to 1.8 +/- 1.0 mmol/liter and 376 +/- 314 mg/dl at 48 h, respectively (P < 0.01). C-Reactive protein increased by 35% at 24 h and by 110% at 48 h of lipid infusion. There were no significant changes in plasma renin and aldosterone levels during lipid or saline infusions. CONCLUSION:Increased FFA levels result in a rapid and sustained elevation in blood pressure, impaired endothelial function, and increased inflammatory markers in obese subjects with type 2 diabetes. The model of FFA-induced hypertension may be useful in examining disease mechanisms associated with the development of hypertension in obese subjects.
RCT Entities:
OBJECTIVE: Increased free fatty acids (FFAs) are leading candidates in the pathogenesis of insulin resistance and hypertension in obese subjects. We evaluated the effect of sustained elevations of FFA on blood pressure, endothelial function, insulin secretion, inflammatory markers, and renin-angiotensin system. RESEARCH DESIGN AND METHODS: Twenty-four obese, African-American, normotensive diabetic subjects received a sequential 48-h infusion of Intralipid (20%, 40 ml/h) plus heparin (250 units/h) or normal saline (40 ml/h) plus heparin (250 units/h). RESULTS: Blood pressure was significantly increased within 4 h of lipid infusion and reached a peak increment of 13 mm Hg in systolic and 5 mm Hg in diastolic blood pressure at 24 h (P < 0.01). Compared to baseline, lipid infusion reduced flow-mediated dilatation by 11% at 24 h and 18% at 48 h (P < 0.001). FFA and triglyceride levels increased from a baseline of 0.5 +/- 0.2 mmol/liter and 135 +/- 76 mg/dl to 1.8 +/- 1.0 mmol/liter and 376 +/- 314 mg/dl at 48 h, respectively (P < 0.01). C-Reactive protein increased by 35% at 24 h and by 110% at 48 h of lipid infusion. There were no significant changes in plasma renin and aldosterone levels during lipid or saline infusions. CONCLUSION: Increased FFA levels result in a rapid and sustained elevation in blood pressure, impaired endothelial function, and increased inflammatory markers in obese subjects with type 2 diabetes. The model of FFA-induced hypertension may be useful in examining disease mechanisms associated with the development of hypertension in obese subjects.
Authors: H O Steinberg; M Tarshoby; R Monestel; G Hook; J Cronin; A Johnson; B Bayazeed; A D Baron Journal: J Clin Invest Date: 1997-09-01 Impact factor: 14.808
Authors: M Roden; T B Price; G Perseghin; K F Petersen; D L Rothman; G W Cline; G I Shulman Journal: J Clin Invest Date: 1996-06-15 Impact factor: 14.808
Authors: A Fagot-Campagna; B Balkau; D Simon; J M Warnet; J R Claude; P Ducimetière; E Eschwège Journal: Int J Epidemiol Date: 1998-10 Impact factor: 7.196
Authors: Aidar R Gosmanov; Dawn D Smiley; Gonzalo Robalino; Joselita Siquiera; Bobby Khan; Ngoc-Anh Le; Riyaz S Patel; Arshed A Quyyumi; Limin Peng; Abbas E Kitabchi; Guillermo E Umpierrez Journal: Am J Physiol Endocrinol Metab Date: 2010-10-05 Impact factor: 4.310
Authors: Joselita Siqueira; Dawn Smiley; Christopher Newton; Ngoc-Anh Le; Aidar R Gosmanov; Ronnie Spiegelman; Limin Peng; Samantha J Osteen; Dean P Jones; Arshed A Quyyumi; Thomas R Ziegler; Guillermo E Umpierrez Journal: J Clin Endocrinol Metab Date: 2011-08-10 Impact factor: 5.958
Authors: Jonathan C Jun; Luciano F Drager; Samer S Najjar; Stephen S Gottlieb; Cynthia D Brown; Philip L Smith; Alan R Schwartz; Vsevolod Y Polotsky Journal: Sleep Date: 2011-09-01 Impact factor: 5.849
Authors: Guillermo E Umpierrez; Dawn Smiley; Gonzalo Robalino; Limin Peng; Aidar R Gosmanov; Abbas E Kitabchi Journal: Diabetes Care Date: 2009-12-22 Impact factor: 17.152
Authors: Francisco J Pasquel; Ronnie Spiegelman; Megan McCauley; Dawn Smiley; Denise Umpierrez; Rachel Johnson; Mary Rhee; Chelsea Gatcliffe; Erica Lin; Erica Umpierrez; Limin Peng; Guillermo E Umpierrez Journal: Diabetes Care Date: 2009-12-29 Impact factor: 19.112